Poster list

A detailed overview of all events can be found in the conference planner.

Filter
Code
Title
P001
SHORT VERSUS LONG POSTSURGICAL ANTIBIOTIC THERAPY FOR SPINAL INFECTIONS (SASI Trials) – SECOND INTERIM ANALYSIS
Poster flash presentation SSI
I. Uçkay Speaker Balgrist University HospitalM. Betz Balgrist University HospitalM. Farshad Balgrist University Hospital
P002
Antifungal drug penetration in infected human body fluids and tissues
Poster flash presentation SSI
A. Cancela Costa Speaker Infectious Diseases Service and Microbiology Institute of Lausanne University Hospital (CHUV)E. Glampedakis Infectious Diseases Service and Microbiology Institute of Lausanne University Hospital (CHUV)A. Kritikos Infectious Diseases Service and Microbiology Institute of Lausanne University Hospital (CHUV)F. Grass University Hospital of Lausanne (CHUV)E. Uldry University Hospital of Lausanne (CHUV)C. Delabays University Hospital of Lausanne (CHUV)J. Perentes University Hospital of Lausanne (CHUV)J. Pagani University Hospital of Lausanne (CHUV)B. Guery Infectious Diseases Service and Microbiology Institute of Lausanne University Hospital (CHUV)J. Da Silva Pereira Clara University Hospital of Lausanne (CHUV)L. Decosterd University Hospital of Lausanne (CHUV)F. Lamoth Infectious Diseases Service and Microbiology Institute of Lausanne University Hospital (CHUV)
P003
HIV-1 drug resistance in patients failing dolutegravir-based regimens: Collaborative analysis of HIV cohort studies
Poster flash presentation SSI
T. Loosli Speaker University and University Hospital of ZurichS. Hossmann University of BernS. Ingle University of BristolK. Kusejko University Hospital of ZurichA. van Sighem Stichting HIV MonitoringM. Stecher German Center for Infection Research (DZIF), Partner-Site Cologne-BonnA. d'Arminio Monforte Italian Cohort Naive Antiretrovirals, (ICONA) L'Azienda Socio Sanitaria Territoriale (ASST) Santi Paolo e CarloJ. Gill University of CalgaryG. Maartens University of Cape TownH. Günthard University and University Hospital of ZurichJ. Sterne University of BristolR. Lessells University of KwaZulu-NatalM. Egger University of BernR. Kouyos Speaker University and University Hospital of Zurich
P004
Evaluation of the impact of on-site PCR testing for N. gonorrhoeae, C. trachomatis, and M. genitalium on the number of blind treatments at a large Swiss STI clinic
Poster flash presentation SSI
K. Wissel Speaker Checkpoint ZurichM. Eugster Unilabs DübendorfM. Laffers Checkpoint ZurichB. Hampel Checkpoint Zurich
P005
Risk and severity of SARS-CoV-2 (re)-infection during the Delta and Omicron waves according to baseline immune status and booster vaccination – a prospective multicentre cohort of health professionals in Switzerland
Poster flash presentation SSI
B. Babouee Flury Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen S. Güsewell Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen T. Egger Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen O. Leal Epitrack, Recife, BrazilA. Brucher Psychiatry Services of the Canton of St. Gallen (South)E. Lemmenmeier Clienia Littenheid AGD. Meier Kleeb Division of Occupational Health, Kantonal Spital BadenJ. Möller Center for Neurological Rehabilitation ZihlschlachtP. Rieder Hirslanden Clinic ZurichM. Ruetti Fuerstenland Toggenburg Hospital Group, Wil, SwitzerlandH. Schmid Central Laboratory, Kantonsspital BadenR. Stocker Hirslanden Clinic ZurichD. Vuichard-Gysin Infectious Diseases and Hospital Epidemiology, Thurgau Hospital Group, Muensterlingen and Frauenfeld, SwitzerlandB. Wiggli Department of Infectious Diseases and Hospital Epidemiology, Kantonsspital BadenU. Besold Geriatric Clinic St. GallenA. McGeer Sinai Health System, Toronto, CanadaL. Risch Labormedizinisches Zentrum Dr Risch Ostschweiz AGA. Friedl Department of Infectious Diseases and Hospital Epidemiology, Kantonsspital BadenM. Schlegel Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen P. Vernazza Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen S. Kuster Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen C. Kahlert Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen P. Kohler Speaker Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen
P006
Within-patient blaOXA-48-bearing IncM1 plasmid dissemination among three Enterobacterales species
Poster flash presentation SSI
R. SIERRA Université de GenèveM. Roch Université de GenèveG. Renzi Geneva University Hospitals and Medical SchoolA. Cherkaoui Geneva University Hospitals and Medical SchoolJ. Schrenzel Geneva University Hospitals and Medical SchoolN. Vuilleumier HUG Hôpitaux Universitaires GenèveD. Andrey Speaker Geneva University Hospitals and Medical School
P007
Effect of SARS-CoV-2 mRNA vaccine booster on humoral and cellular immunity in patients with multiple myeloma and poor response to two-dose primary immunisation
Poster flash presentation SSI
T. Tobias Kantonsspital St. GallenW. Albrich Kantonsspital St. GallenS. Fischer Kantonsspital St. GallenS. Nigg Kantonsspital St. GallenR. Demmer Kantonsspital St. GallenC. Driessen Kantonsspital St. GallenC. Kahlert Speaker Ostschweizer Kinderspital
P008
Infective endocarditis and cardiovascular outcomes after transcatheter and surgical aortic valve replacement: a population-based cohort study
Poster flash presentation SSI
M. Purtak Speaker Kantonspital AarauA. Kutz Kantonsspital AarauA. Conen Kantonsspital Aarau
P009
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients
Poster flash presentation SSI
T. PHAM Speaker Geneva University Hospitals (HUG)D. Andrey Geneva University Hospitals (HUG)S. Susanne Basel University HospitalB. Sara H. Zurich University HospitalC. Hirzel Inselspital - Universitätsspital BernJ. Tschopp CHUV - University HospitalK. Ullrich Basel University HospitalC. Strahm Kantonspital St GallenP. Schreiber Zurich University HospitalN. Boillat-Blanco CHUV - University HospitalC. Garzoni Clinica luganeseN. Khanna Basel University HospitalO. Manuel CHUV - University HospitalN. Mueller Zurich University HospitalD. Suva Geneva University Hospitals (HUG)C. van Delden Geneva University Hospitals (HUG)I. Uçkay Balgrist University Hospital, University of ZürichD. Neofytos Geneva University Hospitals (HUG)
P010
Rapid increase of myeloid-derived suppressor cells and prolonged innate immune dysfunctions in patients with COVID-19
Poster flash presentation SSI
I. Schrijver CHUV Centre Hospitalier Universitaire Vaudois (CHUV)C. Théroude CHUV Centre Hospitalier Universitaire Vaudois (CHUV)C. Gilbert Speaker CHUV Centre Hospitalier Universitaire Vaudois (CHUV)N. Antonakos CHUV Centre Hospitalier Universitaire Vaudois (CHUV)D. Le Roy CHUV Centre Hospitalier Universitaire Vaudois (CHUV)P. Bart CHUV Centre Hospitalier Universitaire Vaudois (CHUV)J. Chiche CHUV Centre Hospitalier Universitaire Vaudois (CHUV)M. Perreau CHUV Centre Hospitalier Universitaire Vaudois (CHUV)G. Pantaleo CHUV Centre Hospitalier Universitaire Vaudois (CHUV)T. Calandra CHUV Centre Hospitalier Universitaire Vaudois (CHUV)T. Roger CHUV Centre Hospitalier Universitaire Vaudois (CHUV)
P011
Staphylococcus epidermidis in implant-associated infections - high rate of multiresistance associated with treatment failure
Poster flash presentation SSI
M. Schumacher Speaker University Hospital Basel SwitzerlandF. Grob University Hospital Basel SwitzerlandA. Egli University Hospital Basel SwitzerlandM. Clauss University Hospital Basel SwitzerlandM. Morgenstern University Hospital Basel SwitzerlandL. Werlen University Hospital Basel SwitzerlandR. Kuehl University Hospital Basel SwitzerlandN. Khanna University Hospital Basel Switzerland
P012
Nanopore selective sequencing of pathogens in clinical samples: Application to SARS-CoV-2 genome sequencing
Poster flash presentation SSI
M. Terrazos Miani Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandL. Borcard Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandS. Gempeler Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandC. Baumann Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandP. Bittel Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandF. Suter-Riniker Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandS. Leib Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandS. Neuenschwander Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandA. Ramette Speaker Institute for Infectious Diseases, University of Bern, Bern, Switzerland
P013
Association of a Covid Vaccine Booster with Control of a COVID-Outbreak in a Long-Term Care Facility in Switzerland, November to December 2021
Poster flash presentation SSHH
T. Leiblein Speaker Hirslanden AndreasKlinikA. Winistörfer Pflegezentrum EnnetseeK. Seiler Pflegezentrum EnnetseeR. Hauri Directorate of HealthR. Sommerstein Speaker Bern University Hospital
P014
Assessing the conversion of electronic patient records data into antibiotic stewardship quality indicators
Poster flash presentation SSHH
L. Renggli Speaker Universität BernC. Plüss-Suard Universität BernM. Gasser Universität BernS. Beat Cantonal Hospital LucerneA. Kronenberg Universität Bern
P015
Routes of transmission of VIM-Pseudomonas aeruginosa in the adult intensive care unit - analysis of 9 years of surveillance at a university hospital using a mathematical model
Poster flash presentation SSHH
T. Pham University Medical Center UtrechtA. Büchler Speaker Erasmus MC, University Medical CenterA. Voor in 't holt Erasmus MC, University Medical CenterJ. Severin Erasmus MC, University Medical CenterM. Bootsma University Medical Center UtrechtD. Gommers Erasmus MC, University Medical CenterM. Kretzschmar University Medical Center UtrechtM. Vos Erasmus MC, University Medical Center
P016
Risk of SARS-CoV-2 acquisition in healthcare workers according to cumulative patient exposure and preferred mask type – a prospective cohort
Poster flash presentation SSHH
T. Dörr Speaker Kantonsspital St. GallenS. Haller Kantonsspital St. GallenM. Müller Hirslanden Clinic ZurichA. Friedl Kantonsspital BadenD. Vuichard-Gysin STGAG Kantonsspital MünsterlingenC. Kahlert Kantonsspital St. GallenP. Kohler Kantonsspital St Gallen
P017
All-cause mortality in residents from long-care-facilities 2020, 2021 compared to pre-pandemic year 2019: data from a multicentre cohort from Eastern and Western Switzerland
Poster flash presentation SSHH
G. Scanferla Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen D. Héquet Unité cantonale hygiène, prévention et contrôle de l’infection, Canton VaudN. Graf Clinical Trials Unit (CTU), Cantonal Hospital St Gallen – St Gallen P. Kohler Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen V. Musa Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen F. Grässli Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen M. Schlegel Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen S. Kessler Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen D. Flury Speaker Kantonsspital St. Gallen
P018
Nosocomial cluster of vancomycin resistant enterococci during COVID-19 pandemic
Poster flash presentation SSHH
M. Van Singer Speaker Service of Hospital Preventive Medicine - Lausanne (Switzerland), Infectious Diseases Service, University Hospital of Lausanne and Lausanne University Hospital - Lausanne (Switzerland)D. Blanc Service of Hospital Preventive Medicine, University Hospital of Lausanne and Lausanne University Hospital - Lausanne (Switzerland)L. Senn Service of Hospital Preventive Medicine, University Hospital of Lausanne and Lausanne University Hospital - Lausanne (Switzerland)B. Grandbastien Service of Hospital Preventive Medicine, University Hospital of Lausanne and Lausanne University Hospital - Lausanne (Switzerland)
P019
Healthcare‑associated infections in COVID-19 and non-COVID-19 intensive care unit patients during the pandemic: a prospective surveillance study
Poster flash presentation SSHH
S. Rüfenacht Speaker Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandM. Ludwinek Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandW. Frick Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandG. Kleger Division of Intensive Care, Cantonal Hospital St Gallen, St Gallen, SwitzerlandF. Schneider Division of Intensive Care, Cantonal Hospital St Gallen, St Gallen, SwitzerlandW. Albrich Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandD. Flury Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandS. Kuster Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandM. Schlegel Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandP. Kohler Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland
P020
Unraveling transmission clusters of SARS-CoV-2 in a tertiary academic care center
Poster flash presentation SSHH
M. von Rotz Speaker University Hospital of BaselA. Durovic Swiss Tropical and Public Health InstituteS. Zingg University Hospital of BaselF. Banderet-Uglioni University Hospital of BaselA. Apitz University Hospital of BaselH. Seth-Smith University Hospital of BaselT. Roloff University Hospital of BaselS. Kuster University Hospital of BaselR. Kühl University Hospital of BaselA. Egli University Hospital of BaselS. Tschudin Sutter University Hospital of Basel
P021
Successful control of two distinct outbreaks of ESBL-producing Klebsiella species in a Paediatric Intensive Care Unit
Poster flash presentation SSHH
A. Cusini Speaker Division of Infectious Diseases, Cantonal Hospital of Grisons, ChurU. Gadola Hospital Hygiene, Cantonal Hospital of Grisons, ChurS. Riess Hospital Hygiene, Cantonal Hospital of Grisons, ChurC. Guler Microbiology, Cantonal Hospital of Grisons, ChurC. Schumacher Department of Pediatrics, Cantonal Hospital of Grisons, ChurN. Binz Department of Pediatrics, Cantonal Hospital of Grisons, ChurH. Seth Smith Division of Clinical Bacteriology and Mycology, University Hospital BaselS. Seiffert Division of Human Microbiology, Centre for Laboratory Medicine, St. GallenF. Fleisch Division of Infectious Diseases, Cantonal Hospital of Grisons, ChurA. Egli Division of Clinical Bacteriology and Mycology, University Hospital Basel
P022
Outbreak of COVID-19 associated aspergillosis in an intensive care unit associated with construction work
Poster flash presentation SSHH
G. Catho Speaker Hopital du Valais (RSV) - Institut Central (ICHV)E. Magualetti Institut Central des Hôpitaux (ICH) - Hopital Du ValaisC. Niggli Institut Central des Hôpitaux (ICH) - Hopital Du ValaisJ. Garcia Martinez Hopital du Valais (HVS) - Centre Hospitalier du Valais RomandX. Alvarez Hopital du Valais (HVS) - Centre Hospitalier du Valais RomandA. Milon Institut Central des Hôpitaux (ICH) - Hopital Du ValaisS. Emonet Institut Central des Hôpitaux (ICH) - Hopital Du Valais
P023
Patients with COVID-19 identified by admission screening and repetitive SARS-CoV-2 screening after admission
Poster flash presentation SSHH
K. Wanner Speaker Universitätsspital ZürichI. Reinhold Universitätsspital ZürichM. Vazquez Universitätsspital ZürichP. Schreiber Universitätsspital ZürichW. Zingg Universitätsspital ZürichA. Wolfensberger Universitätsspital Zürich
P024
Decrease of outpatient antibiotic consumption during the COVID-19 pandemic, Switzerland: an interrupted time series analysis
Poster flash presentation SSHH
C. Plüss-Suard Speaker University of BernO. Friedli University of BernD. Perisa Federal Office of Public HealthM. Mäusezahl Federal Office of Public HealthA. Kronenberg University of Bern
P025
High rates of macrolide resistance in Mycoplasma genitalium among symptomatic patients from a large Swiss STI clinic
Poster SSI
K. Wissel Speaker Checkpoint ZurichM. Eugster Unilabs DübendorfM. Laffers Checkpoint ZurichB. Hampel Checkpoint Zurich
P026
Trained immunity provides durable protection against deadly sepsis
Poster SSI
C. Gilbert Speaker CHUV Centre Hospitalier Universitaire Vaudois (CHUV)E. Ciarlo CHUV Centre Hospitalier Universitaire Vaudois (CHUV)T. Heinonen CHUV Centre Hospitalier Universitaire Vaudois (CHUV)C. Théroude CHUV Centre Hospitalier Universitaire Vaudois (CHUV)M. Reverte CHUV Centre Hospitalier Universitaire Vaudois (CHUV)D. Le Roy CHUV Centre Hospitalier Universitaire Vaudois (CHUV)T. Roger CHUV Centre Hospitalier Universitaire Vaudois (CHUV)
P027
B/F/TAF Five-Year Outcomes in Treatment-Naïve Adults
Poster SSI
D. Wohl UNC School of MedicineA. Pozniak Chelsea and Westminster HospitalK. Workowski Emory UniversityD. Hagins Chatham County Health DepartmentE. Daar Lundquist Institute at Harbor-UCLA Medical CenterC. Orkin Barts Health NHS Trust, Royal London HospitalE. Koenig Instituto Dominicano de Estudios VirólgicosK. Mounzer Philadelphia FIGHT Community Health CentersS. Gupta Indiana University School of MedicineH. Huang Gilead Sciences, Inc.R. Acosta Gilead Sciences, Inc.J. Hindman Gilead Sciences, Inc.J. Baeten Gilead Sciences, Inc.H. Martin Gilead Sciences, Inc.T. Grabinger Speaker Gilead Sciences Switzerland SàrlP. Sax Brigham and Women’s Hospital, Harvard Medical School
P028
Quantification of within-patient Staphylococcus aureus phenotypic heterogeneity as a proxy for presence of persisters across clinical presentations
Poster SSI
J. Bär Speaker University Hospital ZurichM. Boumasmoud University Hospital ZurichS. Mairpady Shambat University Hospital ZurichC. Vulin University Hospital ZurichM. Huemer University Hospital ZurichT. Schweizer University Hospital ZurichA. Gómez-Mejia University Hospital ZurichN. Eberhard University Hospital ZurichY. Achermann University Hospital ZurichP. Zingg Balgrist University HospitalC. Mestres University Hospital ZurichS. Brugger University Hospital ZurichR. Schuepbach University Hospital ZurichR. Kouyos University Hospital ZurichB. Hasse University Hospital ZurichA. Zinkernagel University Hospital Zurich
P029
Resistance Development in Escherichia coli at different pH following Delafloxacin and Ciprofloxacin Challenge
Poster SSI
A. Bösch Medizinisches Forschungszentrum, Kantonsspital St. GallenM. Macha Medizinisches Forschungszentrum, Kantonsspital St. GallenW. Qi ETH ZurichP. Kohler Kantonsspital St. GallenB. Babouee Flury Speaker Kantonsspital St. Gallen
P030
Phenotypic and genotypic characterization of N. gonorrhoeae strains in a population of men who have sex with men with high-risk sexual behavior in Zurich Switzerland
Poster SSI
C. Jünger University Hospital ZurichF. Imkamp University Hospital ZurichS. Balakrishna University Hospital ZurichK. Haldimann University Hospital ZurichM. Gysin University Hospital ZurichB. Hampel Checkpoint ZurichR. Kouyos University Hospital ZurichS. Hobbie University Hospital ZurichH. Günthard University Hospital ZurichD. Braun Speaker UniversitätsSpital Zürich
P031
Clinical and echocardiographic predictors of embolism in infective endocarditis
Poster SSI
M. Papadimitriou-Olivgeris Speaker Lausanne University Hospital (CHUV)P. Monney Lausanne University Hospital (CHUV)M. Kirsch Lausanne University Hospital (CHUV)B. Guery Lausanne University Hospital (CHUV)
P032
High Rates of Virologic Suppression With DTG/3TC in Newly Diagnosed Adults With HIV-1 Infection and Baseline Viral Load > 500,000 c/mL: 48-Week Subgroup Analysis of the STAT Study
Poster SSI
C. Rolle Orlando Immunology Center, Orlando, FL, USAM. Berhe Baylor University Medical Center, Dallas, TX, USAT. Singh DAP Health, Palm Springs, CA, USAR. Ortiz Bliss Healthcare Services, Orlando, FL, USAA. Wurapa Infectious Disease Specialists of Atlanta, Decatur, GA, USAM. Ramgopal Midway Immunology and Research Center, Fort Pierce, FL, USAD. Jayaweera University of Miami Miller School of Medicine, Miami, FL, USAP. Leone ViiV Healthcare, Research Triangle Park, NC, USAJ. Matthews ViiV Healthcare, Research Triangle Park, NC, USAM. Cupo GlaxoSmithKline, Upper Providence, PA, USAM. Underwood ViiV Healthcare, Research Triangle Park, NC, USAK. Angelis GlaxoSmithKline, Brentford, UKC. Nguyen ViiV Healthcare, Research Triangle Park, NC, USAB. Wynne ViiV Healthcare, Research Triangle Park, NC, USAD. Merrill ViiV Healthcare, Research Triangle Park, NC, USAA. Bianchi Speaker ViiV HealthcareM. Mika ViiV Healthcare SwitzerlandJ. van Wyk ViiV Healthcare, Brentford, UKA. Zolopa ViiV Healthcare, Research Triangle Park, NC, USA and Stanford University, Palo Alto, CA, USA
P033
NT-proBNP cut-off as a prognostic marker towards one-year mortality in infective endocarditis
Poster SSI
M. Padrutt Speaker Universitätsspital ZürichB. Ledergerber Universitätsspital ZürichM. Frank Universitätsspital ZürichJ. Epprecht Universitätsspital ZürichM. Greutmann Universitätsspital ZürichJ. Sromicki Universitätsspital ZürichR. Bauernschmitt Universitätsspital ZürichS. Brugger Universitätsspital ZürichA. Zinkernagel Universitätsspital ZürichB. Hasse Universitätsspital Zürich
P034
Effect of COVID-19 on hospitalizations for lower respiratory tract infections in Switzerland: comparison of national data between 2020 and 2015-2019
Poster SSI
C. Bürke Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandF. Baty Lung Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland F. Rassouli Lung Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland M. Brutsche Lung Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland W. Albrich Speaker Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
P035
Pulse oximetry as an aid to rule out pneumonia among patients with a lower respiratory tract infection in primary care
Poster SSI
C. Fischer Speaker CHUV Centre Hospitalier Universitaire Vaudois (CHUV)J. Knusli CHUV Centre Hospitalier Universitaire Vaudois (CHUV)L. Lhopitallier Gare10 Lausanne General PracticeE. Tenisch CHUV Centre Hospitalier Universitaire Vaudois (CHUV)M. Meuwly CHUV Centre Hospitalier Universitaire Vaudois (CHUV)P. Douek CHUV Centre Hospitalier Universitaire Vaudois (CHUV)J. Meuwly CHUV Centre Hospitalier Universitaire Vaudois (CHUV)V. D’Acremont Centre for Primary Care and Public Health, University of LausanneA. Kronenberg IFIK Bern, mediX General Practice NetworkI. Locatelli Centre for Primary Care and Public Health, University of LausanneY. Mueller Centre for Primary Care and Public Health, University of LausanneN. Senn Centre for Primary Care and Public Health, University of LausanneN. Boillat-Blanco CHUV Centre Hospitalier Universitaire Vaudois (CHUV)
P036
Transmission of trained immunity and heterologous resistance to infections across generations
Poster SSI
E. Ciarlo CHUVD. Le Roy CHUVT. Roger Speaker CHUV
P037
Visual motor response of zebrafish larvae is altered upon experimental pneumococcal meningitis
Poster SSI
N. Le Speaker Neuroinfection Laboratory, Institute for Infectious Diseases, University of BernD. Grandgirard Neuroinfection Laboratory, Institute for Infectious Diseases, University of BernS. Leib Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern
P038
IMPACT OF THE COVID-19 PANDEMIC ON INPATIENT ANTIBIOTIC CONSUMPTION IN SWITZERLAND
Poster SSI
O. Friedli Speaker Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of BernM. Gasser Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of BernA. Cusini Cantonal Hospital GraubündenR. Fulchnini Infectious Diseases and Hospital Epidemiology, Thurgau Hospital Group, Muensterlingen and Frauenfeld, Switzerland.D. Vuichard-Gysin Infectious Diseases and Hospital Epidemiology, Thurgau Hospital Group, Muensterlingen and Frauenfeld, Switzerland.N. Wassilew Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.R. Halder Institute of Hospital Pharmacy, Bern University Hospital, University of Bern, SwitzerlandC. Plüss-Suard Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of Bern, Bern, Switzerland.A. Kronenberg Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
P039
Pediatric Hospital Admissions, Case Severity and Length of Hospital Stay during the first 18 months of the COVID-19 pandemic in a tertiary Children‘s Hospital in Switzerland
Poster SSI
J. Bögli Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. GallenS. Güsewell Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. GallenR. Strässle Children’s Hospital of Eastern Switzerland St. Gallen, St. Gallen, SwitzerlandC. Kahlert Children’s Hospital of Eastern Switzerland, Department of Infectious Diseases and Hospital EpidemiologyW. Albrich Speaker Kantonsspital St.Gallen
P040
Overruling of procalcitonin guidance for lower respiratory tract infections in primary care: ancillary study of a randomized controlled trial
Poster SSI
J. Knüsli Speaker Infectious Diseases Service of Lausanne University Hospital (CHUV)L. Lhopitallier gare10.chA. Kronenberg Institut für Infektionskrankheiten, Universität BernJ. Meuwly Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of LausanneO. Opota Microbiology Institute of Lausanne University Hospital (CHUV)M. Perrenoud Microbiology Institute of Lausanne University Hospital (CHUV)M. Page Microbiology Institute of Lausanne University Hospital (CHUV)K. Kain Tropical Disease Unit, Department of Medicine, University of TorontoA. Mamin Division of Infectious Diseases, University Hospital Geneva, University of Geneva, SwitzerlandV. D'Acremont Centre universitaire de médecine générale et santé publique - UnisantéN. Senn Centre universitaire de médecine générale et santé publique - UnisantéY. Mueller Centre universitaire de médecine générale et santé publique - UnisantéI. Locatelli Centre universitaire de médecine générale et santé publique - UnisantéN. Boillat-Blanco Infectious Diseases Service of Lausanne University Hospital (CHUV)
P041
Sex versus Gender-related Characteristics: Which Predicts Clinical Outcomes of Acute COVID-19?
Poster SSI
A. Friedl Speaker Infectious Diseases & Hospital Epidemiology, Departement of Internal Medicine, Kantonsspital Baden, 54040 Baden, SwitzerlandC. Gebhard Intensive Care Unit, University Hospital Basel, Basel, SwitzerlandH. Nadia Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, SwitzerlandS. Bengs Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, SwitzerlandB. Gysi Intensive Care Unit, University Hospital Basel, Basel, SwitzerlandA. Dussault-Cloutier Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, SwitzerlandK. Buehler Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandR. Schuepbach Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandA. Zinkernagel Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandS. Brugger Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland C. Acevedo Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandD. Patriki Department of Internal Medicine, Cantonal Hospital of Baden, Baden, SwitzerlandB. Wiggli Infectious Diseases & Hospital Epidemiology, Departement of Internal Medicine, Kantonsspital Baden, 54040 Baden, SwitzerlandJ. Beer Department of Internal Medicine, Cantonal Hospital of Baden, Baden, SwitzerlandR. Twerenbold Department of Cardiology, University Hospital Basel, Basel, Switzerland and Department of Cardiology and University Center of Cardiovascular Science, University Heart and Vascular Center Hamburg, Hamburg, GermanyG. Kuster Department of Cardiology, University Hospital Basel, Basel, Switzerland and Department of Biomedicine, University of Basel, Basel, SwitzerlandH. Pargger Intensive Care Unit, University Hospital Basel Basel, Switzerland,S. Tschudin-Sutter Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, SwitzerlandJ. Schefold Department of Intensive Care Medicine, Inselspital Bern University Hospital, University of Bern, Bern, SwitzerlandT. Spinetti Department of Intensive Care Medicine, Inselspital Bern University Hospital, University of Bern, Bern, SwitzerlandP. Wendel-Garcia Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandD. Hofmänner Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandT. Scheier Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandA. Todorov Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland and Center for Molecular Cardiology, University of Zurich, Schlieren, SwitzerlandH. Merdji Intensive Care Unit, University Hospital Basel, Basel, Switzerland M. Siegemund Intensive Care Unit, University Hospital Basel, Basel, Switzerland and University of Basel, Basel, SwitzerlandP. Gebert Institute of Biometry and Clinical Epidemiology, Charité – Universitätsmedizin Berlin, Berlin, GermanyV. Regitz-Zagrosek Charité, Universitätsmedizin Berlin, Germany and University of Zurich, Zurich, SwitzerlandC. Gebhard Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland and Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland
P042
Predictors of candidaemia mortality among critically-ill patients: a multicenter retrospective study
Poster SSI
M. Papadimitriou-Olivgeris Speaker Lausanne University Hospital (CHUV)F. Fligou University General Hospital of PatrasF. Lamoth Lausanne University Hospital (CHUV)A. Spiliopoulou University General Hospital of PatrasJ. Pagani Lausanne University Hospital (CHUV)F. Kolonitsiou University General Hospital of PatrasA. Coste Lausanne University Hospital (CHUV)F. Paliogianni University General Hospital of PatrasM. Marangos University General Hospital of PatrasL. Senn Lausanne University Hospital (CHUV)
P043
Hormone intake differentially affects the immune system of HIV-positive cis and trans women
Poster SSI
C. Pasin Speaker Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, SwitzerlandD. Garcia Nuñez University Hospital BaselK. Kusejko University of ZurichA. Hachfeld University Hospital BernK. Aebi-Popp University Hospital BernH. Buvelot University Hospital GenevaM. Cavassini Lausanne University HospitalL. Damonti Regional Hospital LuganoC. Fux Kantonsspital AarauB. Martinez de Tejada University Hospital GenevaP. Vernazza Cantonal Hospital St. GallenA. Trkola Institute of Medical Virology, University of Zurich, SwitzerlandH. Günthard Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, SwitzerlandR. Kouyos Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, SwitzerlandI. Abela Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, Switzerland
P044
High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumosepsis and multi-organ failure
Poster SSI
I. Schrijver CHUV Centre Hospitalier Universitaire Vaudois (CHUV)E. Karakike National and Kapodistrian University of AthensC. Gilbert Speaker CHUV Centre Hospitalier Universitaire Vaudois (CHUV)C. Théroude CHUV Centre Hospitalier Universitaire Vaudois (CHUV)P. Baumgartner CHUV Centre Hospitalier Universitaire Vaudois (CHUV)A. Harari CHUV Centre Hospitalier Universitaire Vaudois (CHUV)E. Giamarellos‑Bourboulis National and Kapodistrian University of AthensT. Calandra CHUV Centre Hospitalier Universitaire Vaudois (CHUV)T. Roger CHUV Centre Hospitalier Universitaire Vaudois (CHUV)
P045
Risk factors for incident active tuberculosis in HIV positive patients in the Swiss HIV Cohort Study
Poster SSI
M. Zeeb Speaker Zurich University HospitalB. Tepekule Zurich University HospitalK. Kusejko Zurich University HospitalD. Braun Zurich University HospitalH. Günthard Zurich University HospitalJ. Notter St. Gallen Cantonal HospitalH. Furrer Insel University Hospital BerneM. Hoffmann Cantonal Hospital OltenH. Hirsch Basel University HospitalA. Calmy Geneva University HospitalM. Cavassini Lausanne University HospitalM. Battegay Basel University HospitalE. Bernasconi Regional Hospital LuganoR. Kouyos Zurich University HospitalJ. Nemeth Zurich University Hospital
P046
Long-acting cabotegravir + rilpivirine every 2 months: week 152 phase 3 randomized clinical trial results
Poster SSI
E. Overton University of Alabama at Birmingham, Birmingham, AL, United StatesG. Richmond Nova Southeastern University, FL, United StatesG. Rizzardini Department of Infectious Diseases, Fatebenefratelli Sacco Hospital, Milan, Italy & School of Clinical Medicine, Faculty of Health Science University of the Witwatersrand, Johannesburg, South AfricaA. Thalme Department of Infectious Diseases, Karolinska University Hospital, Stockholm, SwedenP. Girard Department of Infectious and Tropical Diseases & Inserm, University of Paris, St Antoine Hospital, Paris, FranceA. Wong University of Saskatchewan, Regina, CanadaN. Porteiro Fundacion IDEAA, Buenos Aires, ArgentinaC. Español GlaxoSmithKline, Brentford, United KingdomC. Acuipil GlaxoSmithKline, Buenos Aires, ArgentinaA. Aksar GlaxoSmithKline, Manchester, United KingdomY. Wang GlaxoSmithKline, Collegeville, PA, United StatesR. D’Amico ViiV Healthcare, Research Triangle Park, NC, United StatesC. Talarico ViiV Healthcare, Research Triangle Park, NC, United StatesK. Vandermeulen Janssen Research & Development, Beerse, BelgiumP. Rhein Speaker ViiV Healthcare, Münchenbuchsee, SwitzerlandW. Spreen ViiV Healthcare, Research Triangle Park, NC, United States
P047
TREATMENT WITH BULEVIRTIDE IMPROVES PATIENT REPORTED OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS DELTA (CHD): AN INTERIM EXPLORATORY ANALYSIS AT WEEK 24
Poster SSI
C. Oberle Speaker Gilead Sciences Switzerland SàrlH. Wedemeyer Medizinische Hochschule HannoverS. Aleman Karolinska Universitetssjukhuset, Karolinska lnstitutetV. Chulanov Central Research Institute of EpidemiologyG. Hilgard Universitatsklinikum EssenJ. Antonova Gilead Sciences, Inc.A. Kaushik Gilead Sciences, Inc.A. Lloyd Acaster Lloyd Consulting LtdD. Manuilov Gilead Sciences, Inc.V. Suri Gilead Sciences, Inc.T. Tran Gilead Sciences, Inc.A. Osinusi Gilead Sciences, Inc.P. Lampertico Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, CRC “a.M. and a. Migliavacca” Center for Liver Disease, Universita Degli Studi Di MilanoV. Morozov Hepatolog, LLCO. Sagalova Southern Ural State Medical UniversityT. Stepanova Clinic of Modern MedicineM. Buti Hospital Universitario Valle Hebron
P048
Initiating long-acting cabotegravir and rilpivirine in a real-world setting – clinical characteristics and switch reasons from PLHIV and healthcare provider perspective in the German CARLOS cohort
Poster SSI
C. Wyen Praxis Ebertplatz, Cologne, GermanyJ. Scherzer ViiV Healthcare, Munich, GermanyC. Oldenbüttel MVZ München am Goetheplatz, Munich, GermanyC. Lieb Praxis Goldstein, Berlin, GermanyK. Ummard-Berger 5UBN / Praxis, Berlin, GermanyC. Cordes Praxis Dr. Cordes, Berlin, GermanyN. Postel prinzmed, Munich, GermanyS. Dakhia ViiV Healthcare, Brentford, London UKB. Westermayer GlaxoSmithKline, Munich, GermanyT. Edinger Speaker ViiV Healthcare, Münchenbuchsee, SwitzerlandK. Bernhardt ViiV Healthcare, Munich, Germany
P049
Long-Acting Lenacapavir in People With Multidrug-Resistant HIV-1: Week 52 Results
Poster SSI
O. Ogbuagu Yale University School of MedicineS. Segal-Maurer New York Presbyterian QueensC. Brinson Central Texas Clinical ResearchP. Chetchotisakd Srinagarind HospitalK. Workowski Emory UniversityJ. McGowan North Shore University HospitalH. Wang Gilead Sciences, Inc.N. Margot Gilead Sciences, Inc.H. Dvory-Sobol Gilead Sciences, Inc.M. Rhee Gilead Sciences, Inc.J. Baeten Gilead Sciences, Inc.T. Grabinger Speaker Gilead Sciences Switzerland SàrlJ. Molina Hopital Saint Louis
P050
Behavioral and immune parameters steer susceptibility to SARS-CoV-2 infection in People with HIV in the SWISS HIV Cohort Study (SHCS)
Poster SSI
R. Kouyos Speaker University Hospital and University of Zurich, Zurich, SwitzerlandI. Abela University Hospital and University of Zurich, Zurich, SwitzerlandA. Hauser University Hospital and University of Zurich, Zurich, SwitzerlandM. Schwarzmüller University of ZurichC. Pasin University Hospital and University of Zurich, Zurich, SwitzerlandS. Epp University of ZurichM. Cavassini Lausanne University HospitalM. Battegay University Hospital BaselA. Rauch Bern University HospitalA. Calmy Geneva University HospitalJ. Notter Cantonal Hospital St. GallenE. Bernasconi Regional Hospital LuganoC. Fux Kantonsspital AarauK. Leuzinger University of BaselM. Perreau Lausanne University HospitalA. Ramette University of BernS. Yerly Geneva University HospitalJ. Gottschalk Blood Transfusion Service ZurichE. Schindler Blood Transfusion Service ZurichA. Wolfensberger University Hospital ZurichS. Rampini University Hospital ZurichA. Wepf Cantonal Hospital WinterthurU. Karrer Cantonal Hospital WinterthurM. Marconato University Hospital ZurichM. Manz University Hospital ZurichB. Frey Blood Transfusion Service ZurichD. Braun University Hospital ZurichM. Huber University of ZurichH. Günthard University Hospital and University of Zurich, Zurich, SwitzerlandA. Trkola University of Zurich
P051
Mortality and morbidity related to the Hepatitis C Virus: a propensity score matching analysis using routinely collected data from a large, tertiary hospital in Switzerland
Poster SSI
F. Hovaguimian (Lachmann) Speaker Division of Infectious Disease and Hospital Epidemiology; University Hospital of Zurich and University of ZurichP. Beeler Division of Occupational and Environmental Medicine; Epidemiology, Biostatistics and Prevention Institute, University of Zurich and University Hospital ZurichB. Müllhaupt Department of Gastroenterology and Hepatology, University Hospital of ZurichH. Günthard Division of Infectious Disease and Hospital Epidemiology; University Hospital of Zurich and University of ZurichB. Maeschli Swiss HepatitisP. Bruggmann Arud Centers for Addiction MedicineJ. Fehr Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of ZurichR. Kouyos Division of Infectious Disease and Hospital Epidemiology; University Hospital of Zurich and University of Zurich
P052
Dye hard: Clofazimine affects macrophage activity in vitro and in vivo
Poster SSI
R. Wolfensberger Speaker UZH E. Sarti UZHP. Sander UZHR. Speck USZ / UZHJ. Nemeth USZ
P053
Coagulase-negative Staphylococci other than S. epidermidis and their role in implant-associated infections
Poster SSI
F. Grob Speaker M. Schumacher Universitätsspital BaselA. Egli Universitätsspital BaselM. Clauss Universitätsspital BaselM. Morgenstern Universitätsspital BaselL. Werlen Universitätsspital BaselR. Kuehl Universitätsspital BaselN. Khanna Universitätsspital Basel
P054
Mycobacterium tuberculosis highjacks c-MYC controlled self-renewal programs for intracellular persistence in macrophages
Poster SSI
E. Sarti Speaker Zurich University HospitalR. Wolfensberger Zurich University HospitalP. Sander University of ZurichR. Speck Zurich University HospitalS. Bredl Zurich University HospitalJ. Nemeth Zurich University Hospital
P055
Trends and outcomes of patients hospitalized with COVID-19 during the first and second wave: A nationwide cohort study
Poster SSI
C. Gregoriano Speaker Cantonal Hospital Aarau, Aarau, SwitzerlandK. Rafaisz Cantonal Hospital Aarau, Aarau, Switzerland; University of BaselP. SCHUETZ Cantonal Hospital Aarau, Aarau, Switzerland; University of BaselB. Mueller Cantonal Hospital Aarau, Aarau, Switzerland; University of BaselC. Fux Cantonal Hospital Aarau, Aarau, SwitzerlandA. Conen Cantonal Hospital Aarau, Aarau, SwitzerlandA. Kutz Cantonal Hospital Aarau, Aarau, Switzerland; Brigham and Women's Hospital and Harvard Medical School
P056
The clinical impact of skin commensals as causative pathogens of diabetic foot infections
Poster SSI
I. Uçkay Speaker Balgrist University HospitalK. Gariani Geneva University Hospitals (HUG)
P057
Prevalence of enterococcal groin colonization in patients undergoing cardiac interventions: Challenging antimicrobial prophylaxis with cephalosporins in TAVR patients
Poster SSI
D. Widmer Speaker Universitätsspital BaselA. Widmer Universitätsspital BaselR. Jeger Stadspital TriemliM. Dangel Universitätsspital BaselS. Stortecky Insel Gruppe AG, Inselspital, Universitätsspital BernR. Frei Universitätsspital BaselA. Conen Kantonsspital Aarau
P058
Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24-week interim data of the Phase 3 MYR301 study
Poster SSI
C. Oberle Speaker Gilead Sciences Switzerland SàrlH. Wedemeyer Medizinische Hochschule HannoverS. Aleman Karolinska University Hospital/Karolinska InstitutetM. Brunetto University Hospital of Pisa and Department of Clinical and Experimental MedicineA. Blank Heidelberg University HospitalP. Andreone University of Modena and Reggio EmiliaP. Bogomolov State Budgetary Institution of Health Care of Moscow region “Moscow Regional Research Clinical Institute after M.F. Vladimirsky"V. Chulanov FSBI National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian FederationN. Mamonova FSBI National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian FederationN. Geyvandova Stavropol Regional HospitalV. Morozov LLC Medical Company “Hepatolog” O. Sagalova Federal state-funded institution of higher education "Southern Ural State Medical University of Ministry of Health of the Russian Federation"T. Stepanova LLC “Clinic of Modern Medicine"D. Manuilov Gilead Sciences, Inc.V. Suri Gilead Sciences, Inc.Q. An Gilead Sciences, Inc.J. Flaherty Gilead Sciences, Inc.A. Osinusi Gilead Sciences, Inc.J. Schulze zur Wiesch Universitätsklinikum Hamburg-Eppendorf Medizinische Klinik Studienambulanz HepatologieM. Cornberg Medizinische Hochschule HannoverS. Zeuzem University Hospital FrankfurtP. Lampertico Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico & CRC “A. M. and A. Migliavacca” Center for Liver Disease, University of Milan
P059
Herpesvirus Reactivations in Critically-Ill COVID-19 Patients with Autoantibodies Neutralizing Type I Interferons
Poster SSI
I. Busnadiego University of ZurichI. Abela University Hospital ZurichP. Frey University Hospital ZurichD. Hofmänner University Hospital ZurichT. Scheier University Hospital ZurichR. Schuepbach University Hospital ZurichP. Buehler University Hospital ZurichS. Brugger University Hospital ZurichB. Hale Speaker University of Zurich
P060
A qualitative exploration of HIV stigma and its impact on accessing healthcare
Poster SSI
D. Jackson-Perry Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)C. Le Saux Speaker Centre universitaire de médecine générale et santé publique - UnisantéI. Gilles Centre universitaire de médecine générale et santé publique - UnisantéC. Storari Centre universitaire de médecine générale et santé publique - UnisantéO. Keserue Pittet Centre universitaire de médecine générale et santé publique - UnisantéO. Nawej Tshikung HUG Hôpitaux Universitaires GenèveE. Cart Centre universitaire de médecine générale et santé publique - UnisantéM. Cavassini Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)K. Darling Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
P061
The GENeva PHage (GENPH) collection against carbapenem-resistant Klebsiella pneumoniae
Poster SSI
R. Sierra Geneva University Hospitals and Medical SchoolD. Jaquier Geneva University Hospitals and Medical SchoolM. Roch Université de GenèveD. Andrey Speaker Geneva University Hospitals and Medical School
P062
Intensified screening for chronic hepatitis B in Macenta, Republic of Guinea: a prospective cohort study
Poster SSI
C. Henzen Speaker Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandJ. Hebelamou Centre Hospitalier Régional Spécialisé, Macenta, GuineaY. Guilavogui Centre Hospitalier Régional Spécialisé, Macenta, GuineaA. Rauch Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandS. Onivogui Centre Hospitalier Régional Spécialisé, Macenta, GuineaC. Fux Department of Infectious Diseases, Kantonsspital Aarau, Aarau, SwitzerlandM. Seydi Centre Hospitalier National Universitaire (CHNU) Fann, Dakar, SenegalC. Staehelin Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandD. Leuenberger Department of Infectious Diseases, Kantonsspital Aarau, Aarau, Switzerland
P063
An uncommon cause of PJI – a case report
Poster SSI
P. Aebi Speaker Cantonal Hospital OltenP. Märzendorfer Cantonal Hospital OltenM. Hoffmann Cantonal Hospital Olten
P064
Clinical presentation and disease course of clinical pneumonia in primary care according to microbiological etiology: ancillary study of a randomized controlled trial
Poster SSI
J. Knüsli Speaker Infectious Diseases Service of Lausanne University Hospital (CHUV)L. Lhopitallier gare10.chA. Kronenberg Institut für Infektionskrankheiten, Universität BernJ. Meuwly Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of LausanneO. Opota Microbiology Institute of Lausanne University Hospital (CHUV)M. Perrenoud Microbiology Institute of Lausanne University Hospital (CHUV)M. Page Microbiology Institute of Lausanne University Hospital (CHUV)A. Mamin Division of Infectious Diseases, University Hospital Geneva, University of Geneva, SwitzerlandV. D'Acremont Centre universitaire de médecine générale et santé publique - UnisantéI. Locatelli Centre universitaire de médecine générale et santé publique - UnisantéN. Senn Centre universitaire de médecine générale et santé publique - UnisantéY. Mueller Centre universitaire de médecine générale et santé publique - UnisantéN. Boillat-Blanco Infectious Diseases Service of Lausanne University Hospital (CHUV)
P065
The influence of the timing and sequence of revascularization (before or after amputation) on the outcomes of diabetic foot infections - a single-centre, retrospective pilot evaluation
Poster SSI
I. Uçkay Speaker Balgrist University HospitalM. Schöni Balgrist University HospitalM. Berli Balgrist University HospitalF. Waibel Balgrist University Hospital
P066
Nutritional Interventions Might Help to Improve the Management of Operated Diabetic Foot Infections - A Single-Centre Case-Control Study
Poster SSI
I. Uçkay Speaker Balgrist University HospitalV. Yogarasa Balgrist University HospitalF. Waibel Balgrist University HospitalM. Schöni Balgrist University Hospital
P067
Systemic Spiroplasma turonicum infection in an immunosuppressed patient
Poster SSI
R. Berger Spital Thun STS AGN. Kerstin Viollier AGD. Ernst Spital Thun STS AGT. Zehnder Spital Thun STS AGT. Wendland Speaker Spital Thun STS AG
P068
Archived Resistance and Response to < 40 c/mL and TND: DTG/3TC FDC at Week 48 in SALSA
Poster SSI
M. Underwood ViiV Healthcare, Research Triangle Park, NCO. Osiyemi Triple O Research Institute PA, West Palm Beach, FL, USR. Rubio Department of Internal Medicine, Hospital Universitario 12 de Octubre, UCM, Madrid, SpainL. Hocqueloux 4Centre Hospitalier Régional d’Orléans, Orléans, FranceN. Porteiro Fundacion IDEAA, Buenos Aires, ArgentinaO. Degen Universitätsklinikum Hamburg-Eppendorf, Hamburg, GermanyJ. Oyee GlaxoSmithKline, Brentford, UKJ. Horton Parexel International, Durham, NC, USAC. Parry ViiV Healthcare, Brentford, UKR. Wang ViiV Healthcare, Research Triangle Park, NC, USAM. Sithamparanathan ViiV Healthcare, Brentford, UKJ. van Wyk ViiV Healthcare, Brentford, UKB. Wynne ViiV Healthcare, Research Triangle Park, NC, USAC. Man ViiV Healthcare, Research Triangle Park, NC, USAM. Mika Speaker ViiV Healthcare SwitzerlandE. Blair ViiV Healthcare, Research Triangle Park, NC, USA
P069
Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) for the treatment of people living with HIV (PLWH): 12-month (12M) effectiveness, persistence, and safety in a multi-country cohort study
Poster SSI
J. Mallolas Hospital Clinic of BarcelonaV. Esposito Cotugno HospitalL. Hocqueloux Orléans Regional HospitalJ. Lambert Mater Misericordiae University HospitalI. Levy Sheba Medical Center, Tel Hashomer HospitalC. Wyen Praxis am ErbertplatzB. van Welzen University Medical Centre UtrechtA. Ustianowski North Manchester General HospitalS. Schreiber Gilead Sciences GmbHD. Thorpe Gilead Sciences Europe LtdM. Heinzkill Gilead Sciences GmbHA. Marongiu Gilead Sciences Europe LtdA. Marongiu Gilead Sciences Europe LtdC. Oberle Speaker Gilead Sciences Switzerland SàrlH. Loemba Montfort Hospital
P070
Clinical and imaging features of COVID-19 associated pulmo-nary aspergillosis
Poster SSI
T. Fischer Cantonal Hospital, St. GallenY. El Baz Cantonal Hospital St. GallenN. Graf St. Gallen Cantonal HospitalS. Wildermuth St. Gallen Cantonal HospitalS. Leschka St. Gallen Cantonal HospitalG. Kleger St. Gallen Cantonal HospitalU. Pietsch St. Gallen Cantonal HospitalM. Frischknecht St. Gallen Cantonal HospitalG. Scanferla St. Gallen Cantonal HospitalC. Strahm St. Gallen Cantonal HospitalS. Wälti St. Gallen Cantonal HospitalT. Dittrich St. Gallen Cantonal HospitalW. Albrich Speaker Kantonsspital St.Gallen
P071
Systematic Review and Meta-Analysis of Integrated Studies on Salmonella and Campylobacter Prevalence, Serovar, and Phenotyping and Genetic of Antimicrobial Resistance in the Middle East—A One Health Perspective
Poster SSI
S. Abukhattab Speaker Swiss Tropcial and Public Health Institute Basel & University of Basel, Basel, SwitzerlandH. Taweel Birzeit UniversityA. Awad Birzeit UniversityL. Crump Swiss Tropcial and Public Health Institute Basel & University of Basel, Basel, SwitzerlandP. Vonaesch University of Lausanne (UNIL), Faculty of Biology and Medicine, Lausanne, Switzerland.J. Zinsstag Swiss Tropical and Public Health Institute & University of Basel, Basel, SwitzerlandJ. Hattendorf Swiss Tropical and Public Health Institute & University of Basel, Basel, SwitzerlandN. Abu-Rmeileh Birzeit University
P072
An extensive case of bone tuberculosis – a case report
Poster SSI
P. Aebi Speaker Cantonal Hospital OltenS. Cronenberg Cantonal Hospital OltenM. Schmelz Cantonal Hospital OltenM. Hoffmann Cantonal Hospital Olten
P073
Combining antibiotics to curb antibiotic resistance: A systematic review and meta-analysis
Poster SSI
B. Siedentop Speaker Institute of Integrative Biology, ETH Zurich, Zurich, SwitzerlandV. Kachalov Health Geography and Policy Group, ETH Zurich, Zurich, Switzerland C. Witzany Institute of Integrative Biology, ETH Zurich, Zurich, SwitzerlandA. Hauser Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, SwitzerlandM. Egger Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland R. Kouyos Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, SwitzerlandS. Bonhoeffer Institute of Integrative Biology, ETH Zurich, Zurich, Switzerland
P074 (O04)
Digital Infection Control - Part I: CAUTI-Surveillance
Poster SSHH Best project (innovation/implementation)SSHH
S. Räz Speaker Kantonsspital BadenA. Sommer Indema AGA. Friedl Kantonsspital BadenB. Wiggli Speaker Kantonsspital Baden
P075 (O04)
Digital Infection Control - Part II: Antibiotic Stewardship Dashboard
Poster SSHH Best project (innovation/implementation)SSHH
B. Wiggli Speaker Kantonsspital BadenL. Fischer AWK Group AGP. Wiedemeier Kantonsspital BadenA. Friedl Kantonsspital Baden
P076 (O04)
Digital Infection Control – Part III: Microbiology & Resistance Surveillance
Poster SSHH Best project (innovation/implementation)SSHH
D. De Courten Speaker Indema AGI. Sen Kantonsspital BadenA. Friedl Kantonsspital BadenB. Wiggli Speaker Kantonsspital Baden
P077 (O04)
Digital Infection Control – Part IV: Daily Routine Support
Poster SSHH Best project (innovation/implementation)SSHH
B. Wiggli Speaker Kantonsspital BadenL. Deshe Kantonsspital BadenL. Fischer AWK Group AGT. Kneschke Kantonsspital BadenA. Friedl Kantonsspital Baden
P078
Investigation associating the postoperative carriage of urinary catheters to (Gram-negative) surgical site infections in elective spine surgery
Poster SSHH
I. Uçkay Speaker Balgrist University HospitalA. Ansorge Balgrist University Hospital
P079
Increased hand hygiene adherence in hospitals during high SARS-CoV-2 activity – data from a Swiss national surveillance system
Poster SSHH
S. Rüfenacht Speaker Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandP. Kohler Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandR. Kuhn Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandD. Flury Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandA. Widmer Swissnoso, Swiss Centre for Infection Prevention, Bern, SwitzerlandM. Schlegel Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland
P080
Multifunktionale Pflegewagen im Pflegealltag: Sind sie ein Risiko für Keimübertragungen?
Poster SSHH
M. Bühler Speaker Universitätsspital Basel, Klink für Infektiologie & SpitalhygieneM. Wicki Jauslin Universitätsspital Basel, Klink für Infektiologie & SpitalhygieneM. Dangel Universitätsspital Basel, Klink für Infektiologie & SpitalhygieneS. Tschudin Sutter Universitätsspital Basel, Klink für Infektiologie & Spitalhygiene
P081
Das Phantom des Bacillus cereus
Poster SSHH
M. Meier Speaker UniversitätsSpital Zürich (USZ)A. Wolfensberger UniversitätsSpital Zürich (USZ)J. Fontijn UniversitätsSpital Zürich (USZ)M. Bryant UniversitätsSpital ZürichB. Chakrakodi UniversitätsSpital Zürich (USZ)B. Duvnjak UniversitätsSpital Zürich (USZ)A. Frey Zuger Kantonsspital AGW. Zingg UniversitätsSpital Zürich (USZ)
P082
Screening of contact patients in multidrug-resistant organism (MDRO) carriers: focus on hospitalized patients is sufficient
Poster SSHH
J. Männer Speaker Cantonal Hospital of St. GallenN. Bloch Cantonal Hospital of St. GallenP. Kohler Cantonal Hospital of St. GallenM. Schlegel Cantonal Hospital of St. GallenD. Flury Cantonal Hospital of St. Gallen
P083
Report of the first nosocomial outbreak of vancomycin-resistant Enterococcus faecium (VRE) ST796 in Europe
Poster SSHH
V. Piezzi Speaker Inselspital, University Hospital BernN. Wassilew Inselspital, University Hospital BernA. Atkinson Inselspital, University Hospital BernS. D'Incau Lucerne Cantonal HospitalT. Kaspar Inselspital, University Hospital BernH. Seth-Smith University and University Hospital BaselC. Casanova Institute for Infectious Diseases, University of BernP. Bittel Institute for Infectious Diseases, University of BernP. Jent Inselspital, University Hospital BernR. Sommerstein Inselspital, University Hospital BernN. Buetti Geneva University Hospitals and Faculty of MedicineJ. Marschall Washington University School of Medicine
P084
Outbreak of Klebsiella pneumoniae producing NDM carbapenemase in a 10-bed neurosurgical intermediate care unit: potential role of sink traps
Poster SSHH
E. Moulin CHUV Centre Hospitalier Universitaire Vaudois (CHUV)P. Filippidis CHUV Centre Hospitalier Universitaire Vaudois (CHUV)C. Aymon Paire-Ficout CHUV Centre Hospitalier Universitaire Vaudois (CHUV)D. Blanc CHUV Centre Hospitalier Universitaire Vaudois (CHUV)B. Grandbastien CHUV Centre Hospitalier Universitaire Vaudois (CHUV)L. Senn CHUV Centre Hospitalier Universitaire Vaudois (CHUV)E. Moulin Speaker CHUV Centre hospitalier universitaire vaudois
P085
Outbreak of nosocomial influenza during a COVID-19 wave in a rehabilitation unit
Poster SSHH
A. Audrey Speaker Institut Central des Hôpitaux (ICH)C. Laubrières Institut Central des Hôpitaux (ICH)L. Vernier Institut Central des Hôpitaux (ICH)A. Dumoulin Institut Central des Hôpitaux (ICH)D. Berthod Institut Central des Hôpitaux (ICH)G. Catho Institut Central des Hôpitaux (ICH)
P086
Outbreak of nosocomial parainfluenza 3 in a nursing home while relaxing COVID-19 measures
Poster SSHH
C. Schuttel Speaker Institut Central des Hôpitaux (ICH) - Hopital Du ValaisP. Beck Institut Central des Hôpitaux (ICH) - Hopital Du ValaisJ. Ferreira Nuring home Le CarillonR. Genoud Nuring home Le CarillonS. Oggier Nuring home Le CarillonE. May Institut Central des Hôpitaux (ICH) - Hopital Du ValaisF. Bally Institut Central des Hôpitaux (ICH) - Hopital Du ValaisG. Catho Institut Central des Hôpitaux (ICH) - Hopital Du Valais
P087
Contact investigations of patients and the environment after identifying carbapenem-resistant Pseudomonas aeruginosa: a systematic review of the literature
Poster SSHH
A. Büchler Speaker Erasmus MC, University Medical CenterS. Shahab Erasmus MC, University Medical CenterJ. Severin Erasmus MC, University Medical CenterM. Vos Erasmus MC, University Medical CenterA. Voor in 't holt Erasmus MC, University Medical Center
P088
Risk factors for postoperative infection in colorectal surgery
Poster SSHH
N. Bloch Speaker Kantonsspital St GallenR. Kuhn Kantonsspital St GallenW. Brunner Kantonsspital St. GallenS. Kuster Kantonsspital St GallenD. Flury Kantonsspital St GallenM. Schlegel Kantonsspital St GallenP. Kohler Kantonsspital St Gallen
P089
Adherence with infection prevention guidelines during the COVID-19 pandemic in long-term care facilities: data from a multicentre cohort from Eastern and Western Switzerland.
Poster SSHH
G. Scanferla Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen D. Hequet Unité cantonale hygiène, prévention et contrôle de l’infection, Canton VaudN. Graf Clinical Trials Unit (CTU), Cantonal Hospital St Gallen – St Gallen (Switzerland)F. Grässli Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen V. Musa Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen M. Schlegel Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen S. Kessler Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen D. Flury Speaker Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen
P090
surveillance des infections en dialyse : expérience du CHUV
Poster SSHH
a. Lacot Speaker service de maladies infectieuses, CHUV Centre hospitalier universitaire vaudoisM. Pruijm service de néphrologie, CHUV Centre hospitalier universitaire vaudoisS. Kissling service de néphrologie, CHUV Centre hospitalier universitaire vaudoisA. Vital-Heilbronn service de maladies infectieuses, CHUV Centre hospitalier universitaire vaudoisI. Federli-Hanachi service de maladies infectieuses, CHUV Centre hospitalier universitaire vaudoisL. Senn service de maladies infectieuses, CHUV Centre hospitalier universitaire vaudoisB. Grandbastien service de maladies infectieuses, CHUV Centre hospitalier universitaire vaudois
P091
Parallel dynamics in the yield of universal SARS-CoV-2 admission screening and population incidence
Poster SSHH
P. Schreiber Speaker University Hospital Zurich and University of Zurich, SwitzerlandT. Scheier University Hospital Zurich and University of Zurich, SwitzerlandA. Wolfensberger University Hospital Zurich and University of Zurich, SwitzerlandD. Saleschus University Hospital Zurich and University of Zurich, SwitzerlandM. Vazquez University Hospital Zurich and University of Zurich, SwitzerlandR. Kouyos University Hospital Zurich and University of Zurich, SwitzerlandW. Zingg University Hospital Zurich and University of Zurich, Switzerland
P092
Fallbericht einer Legionellose in der SARS CoV2 Pandemie
Poster SSHH
B. Müller-Steiert Speaker Bürgerspital SolothurnM. Schärer Klinik für Infektiologie und Spitalhygiene der Solothurner Spitäler AGR. Piso Kantonsspital OltenB. Dübi Kantonsärztlicher Dienst SolothurnM. Hoffmann Kantonsspital Olten
P093
Händehygienekenntnisse im Spital ausserhalb der 5 Indikationen
Poster SSHH
N. Bragatto-Hess Speaker Uniklinik BalgristT. Studhalter Uniklinik Balgrist
P094
Fardeau de la COVID-19 dans les EMS Vaudois au courant de l’année 2021
Poster SSHH
C. Riccio Speaker Unité cantonale vaudoise HPCIE. Glampedakis Unité cantonale HPCI VaudM. Nahimana-Tessemo Unité cantonale HPCI VaudL. Qalla Widmer Unité cantonale HPCI Vaud
P095
Spitalhygienischer Case Report: Legionellen-Kontamination: Aufwändiges Massnahmenpaket oder keep it simple?
Poster SSHH
E. Rolli Speaker Inselspital, Universitätsspital BernN. Wassilew Inselspital, Universitätsspital BernJ. Brunner Inselspital, Universitätsspital BernT. Thalmann Inselspital, Universitätsspital BernP. Jent Inselspital, Universitätsspital BernM. Birrer Inselspital, Universitätsspital Bern
P096
COVID-19 vaccine uptake and its determinants in long-term care facilities: data from a multicentre cohort of LTCFs from Eastern and Western Switzerland.
Poster SSHH
G. Scanferla Cantonal Hospital St. GallenD. Héquet Unité cantonale hygiène, prévention et contrôle de l'infectionN. Graf Cantonal Hospital St. GallenP. Kohler Cantonal Hospital St. GallenA. Nussbaumer Cantonal Hospital St. GallenM. Schlegel Cantonal Hospital St. GallenS. Kessler Cantonal Hospital St. GallenD. Flury Speaker Cantonal Hospital St. Gallen
P097
The drawback of false positive MRSA results with rapid PCR screening during an outbreak
Poster SSHH
D. Blanc Speaker Centre Hospitalier Universitaire VaudoisI. Federli Centre Hospitalier Universitaire VaudoisL. Senn Centre Hospitalier Universitaire VaudoisB. Grandbastien Centre Hospitalier Universitaire Vaudois
P098
Implementing a new screening algorithm for multi-drug resistant organisms in a patient coming from abroad or from risk areas within Switzerland
Poster SSHH
J. Männer Speaker Cantonal Hospital of St. GallenJ. Notter Cantonal Hospital of St. GallenM. Schlegel Cantonal Hospital of St. GallenD. Flury Cantonal Hospital of St. Gallen
P099
P100
Risikobewertung des PlasmaTYPHOON Eine Alternative zu herkömmlichen Trocknungs- und Lagerungssystemen von flexiblen Endoskopen?
Poster SSHH
Y. Fietze Speaker Inselgruppe AG, Inselspital BernT. Thalmann Universitätsklinik für Infektiologie, Abteilung für Spitalhygiene, Inselgruppe, Inselspital BernO. Al-Khalil Department Gesundheit und Soziales J. Marschall Division of Infectious Diseases, Washington University School of MedicineP. Jent Universitätsklinik für Infektiologie, Abteilung für Spitalhygiene, Inselgruppe, Inselspital Bern